Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,425,517 papers from all fields of science
Search
Sign In
Create Free Account
bendazac lysine
Known as:
bendazac lysine salt
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Broader (3)
Anti-Inflammatory Agents, Non-Steroidal
Hypolipidemic Agents
Indazoles
Narrower (1)
Bendalina
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
PROTECTIVE EFFECTS OF BENDAZAC LYSINE ON DIABETIC PERIPHERAL NEUROPATHY IN STREPTOZOTOCIN‐INDUCED DIABETIC RATS
Junxian Yu
,
Yin-di Zhang
,
+4 authors
Shaojun Jiang
Clinical and Experimental Pharmacology and…
2006
Corpus ID: 46482468
1 Diabetic neuropathy is a many faceted complication of both type I and II diabetes. The aim of the present study was to…
Expand
2005
2005
Protective effects of bendazac lysine on early experimental diabetic nephropathy in rats
Xiao‐xing Yin
,
Yin-di Zhang
,
+6 authors
Xiao-gang Zheng
Acta Pharmacologica Sinica
2005
Corpus ID: 32676288
AbstractAim:To investigate the preventive and protective effects of bendazac lysine (BDL) on experimental early diabetic…
Expand
2005
2005
Protective effects of bendazac lysine on early experimental diabetic nephropathy in rats
Xiao-xingYINI
,
Yin-diZHANG
,
+6 authors
Xiao-gangZHENG
2005
Corpus ID: 54158826
Aim: To investigate the preventive and protective effects of bendazac lysine (BDL) on experimental early diabetic nephropathy (DN…
Expand
1993
1993
Clinical study of bendazac lysine for in vivo contact lens cleaning.
T. C. Evans
,
B. Levy
,
J. Szabocsik
Optometry and Vision Science
1993
Corpus ID: 25788816
Bendazac Lysine (BZL), a nonsteroidal anti-inflammatory drug (NSAID), prevents denaturation of proteins secondary to chemical and…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE